Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody Read more →
Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study Read more →
Danaher buys patient monitoring specialist Masimo in $9.9B deal Read more →
